Formulating RALA/Au nanocomplexes to enhance nanoparticle internalisation efficiency, sensitising prostate tumour models to radiation treatment

Abstract Background Gold nanoparticles (AuNP) are effective radiosensitisers, however, successful clinical translation has been impeded by short systemic circulation times and poor internalisation efficiency. This work examines the potential of RALA, a short amphipathic peptide, to enhance the uptak...

Full description

Bibliographic Details
Main Authors: Lindsey A. Bennie, Jie Feng, Christopher Emmerson, Wendy B. Hyland, Kyle B. Matchett, Helen O. McCarthy, Jonathan A. Coulter
Format: Article
Language:English
Published: BMC 2021-09-01
Series:Journal of Nanobiotechnology
Subjects:
Online Access:https://doi.org/10.1186/s12951-021-01019-8
id doaj-7e5641acdb7d44ffa88ca6b2e0d590dd
record_format Article
spelling doaj-7e5641acdb7d44ffa88ca6b2e0d590dd2021-09-26T11:38:32ZengBMCJournal of Nanobiotechnology1477-31552021-09-0119111310.1186/s12951-021-01019-8Formulating RALA/Au nanocomplexes to enhance nanoparticle internalisation efficiency, sensitising prostate tumour models to radiation treatmentLindsey A. Bennie0Jie Feng1Christopher Emmerson2Wendy B. Hyland3Kyle B. Matchett4Helen O. McCarthy5Jonathan A. Coulter6School of Pharmacy, Queen’s University BelfastSchool of Pharmacy, Queen’s University BelfastSchool of Pharmacy, Queen’s University BelfastWestern Health & Social Care Trust, North West Cancer Centre, Altnagelvin HospitalNorthern Ireland Centre for Stratified Medicine, C-TRIC, Altnagelvin Hospital CampusSchool of Pharmacy, Queen’s University BelfastSchool of Pharmacy, Queen’s University BelfastAbstract Background Gold nanoparticles (AuNP) are effective radiosensitisers, however, successful clinical translation has been impeded by short systemic circulation times and poor internalisation efficiency. This work examines the potential of RALA, a short amphipathic peptide, to enhance the uptake efficiency of negatively charged AuNPs in tumour cells, detailing the subsequent impact of AuNP internalisation on tumour cell radiation sensitivity. Results RALA/Au nanoparticles were formed by optimising the ratio of RALA to citrate capped AuNPs, with assembly occurring through electrostatic interactions. Physical nanoparticle characteristics were determined by UV–vis spectroscopy and dynamic light scattering. Nano-complexes successfully formed at w:w ratios > 20:1 (20 µg RALA:1 µg AuNP) yielding positively charged nanoparticles, sized < 110 nm with PDI values < 0.52. ICP-MS demonstrated that RALA enhanced AuNP internalisation by more than threefold in both PC-3 and DU145 prostate cancer cell models, without causing significant toxicity. Importantly, all RALA-AuNP formulations significantly increased prostate cancer cell radiosensitivity. This effect was greatest using the 25:1 RALA-AuNP formulation, producing a dose enhancement effect (DEF) of 1.54 in PC3 cells. Using clinical radiation energies (6 MV) RALA-AuNP also significantly augmented radiation sensitivity. Mechanistic studies support RALA-AuNP nuclear accumulation resulting in increased DNA damage yields. Conclusions This is the first study to demonstrate meaningful radiosensitisation using low microgram AuNP treatment concentrations. This effect was achieved using RALA, providing functional evidence to support our previous imaging study indicating RALA-AuNP nuclear accumulation. Graphic abstracthttps://doi.org/10.1186/s12951-021-01019-8Gold nanoparticlesRALARadiosensitisationProstate cancerNanomedicine
collection DOAJ
language English
format Article
sources DOAJ
author Lindsey A. Bennie
Jie Feng
Christopher Emmerson
Wendy B. Hyland
Kyle B. Matchett
Helen O. McCarthy
Jonathan A. Coulter
spellingShingle Lindsey A. Bennie
Jie Feng
Christopher Emmerson
Wendy B. Hyland
Kyle B. Matchett
Helen O. McCarthy
Jonathan A. Coulter
Formulating RALA/Au nanocomplexes to enhance nanoparticle internalisation efficiency, sensitising prostate tumour models to radiation treatment
Journal of Nanobiotechnology
Gold nanoparticles
RALA
Radiosensitisation
Prostate cancer
Nanomedicine
author_facet Lindsey A. Bennie
Jie Feng
Christopher Emmerson
Wendy B. Hyland
Kyle B. Matchett
Helen O. McCarthy
Jonathan A. Coulter
author_sort Lindsey A. Bennie
title Formulating RALA/Au nanocomplexes to enhance nanoparticle internalisation efficiency, sensitising prostate tumour models to radiation treatment
title_short Formulating RALA/Au nanocomplexes to enhance nanoparticle internalisation efficiency, sensitising prostate tumour models to radiation treatment
title_full Formulating RALA/Au nanocomplexes to enhance nanoparticle internalisation efficiency, sensitising prostate tumour models to radiation treatment
title_fullStr Formulating RALA/Au nanocomplexes to enhance nanoparticle internalisation efficiency, sensitising prostate tumour models to radiation treatment
title_full_unstemmed Formulating RALA/Au nanocomplexes to enhance nanoparticle internalisation efficiency, sensitising prostate tumour models to radiation treatment
title_sort formulating rala/au nanocomplexes to enhance nanoparticle internalisation efficiency, sensitising prostate tumour models to radiation treatment
publisher BMC
series Journal of Nanobiotechnology
issn 1477-3155
publishDate 2021-09-01
description Abstract Background Gold nanoparticles (AuNP) are effective radiosensitisers, however, successful clinical translation has been impeded by short systemic circulation times and poor internalisation efficiency. This work examines the potential of RALA, a short amphipathic peptide, to enhance the uptake efficiency of negatively charged AuNPs in tumour cells, detailing the subsequent impact of AuNP internalisation on tumour cell radiation sensitivity. Results RALA/Au nanoparticles were formed by optimising the ratio of RALA to citrate capped AuNPs, with assembly occurring through electrostatic interactions. Physical nanoparticle characteristics were determined by UV–vis spectroscopy and dynamic light scattering. Nano-complexes successfully formed at w:w ratios > 20:1 (20 µg RALA:1 µg AuNP) yielding positively charged nanoparticles, sized < 110 nm with PDI values < 0.52. ICP-MS demonstrated that RALA enhanced AuNP internalisation by more than threefold in both PC-3 and DU145 prostate cancer cell models, without causing significant toxicity. Importantly, all RALA-AuNP formulations significantly increased prostate cancer cell radiosensitivity. This effect was greatest using the 25:1 RALA-AuNP formulation, producing a dose enhancement effect (DEF) of 1.54 in PC3 cells. Using clinical radiation energies (6 MV) RALA-AuNP also significantly augmented radiation sensitivity. Mechanistic studies support RALA-AuNP nuclear accumulation resulting in increased DNA damage yields. Conclusions This is the first study to demonstrate meaningful radiosensitisation using low microgram AuNP treatment concentrations. This effect was achieved using RALA, providing functional evidence to support our previous imaging study indicating RALA-AuNP nuclear accumulation. Graphic abstract
topic Gold nanoparticles
RALA
Radiosensitisation
Prostate cancer
Nanomedicine
url https://doi.org/10.1186/s12951-021-01019-8
work_keys_str_mv AT lindseyabennie formulatingralaaunanocomplexestoenhancenanoparticleinternalisationefficiencysensitisingprostatetumourmodelstoradiationtreatment
AT jiefeng formulatingralaaunanocomplexestoenhancenanoparticleinternalisationefficiencysensitisingprostatetumourmodelstoradiationtreatment
AT christopheremmerson formulatingralaaunanocomplexestoenhancenanoparticleinternalisationefficiencysensitisingprostatetumourmodelstoradiationtreatment
AT wendybhyland formulatingralaaunanocomplexestoenhancenanoparticleinternalisationefficiencysensitisingprostatetumourmodelstoradiationtreatment
AT kylebmatchett formulatingralaaunanocomplexestoenhancenanoparticleinternalisationefficiencysensitisingprostatetumourmodelstoradiationtreatment
AT helenomccarthy formulatingralaaunanocomplexestoenhancenanoparticleinternalisationefficiencysensitisingprostatetumourmodelstoradiationtreatment
AT jonathanacoulter formulatingralaaunanocomplexestoenhancenanoparticleinternalisationefficiencysensitisingprostatetumourmodelstoradiationtreatment
_version_ 1716867839034392576